investigational

InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold™

CAMBRIDGE, Mass., Oct 23, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a 12-month post-implant update for the first…